Beijing Tong Ren Tang Chinese Medicine Co., Ltd. (BJTRF)
0.6484
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Beijing Tong Ren Tang Chinese Medicine Max Drawdown (5Y) : 56.77% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 56.77% |
| April 30, 2026 | 56.77% |
| March 31, 2026 | 56.77% |
| February 28, 2026 | 56.77% |
| January 31, 2026 | 56.77% |
| December 31, 2025 | 56.77% |
| November 30, 2025 | 56.77% |
| Date | Value |
|---|---|
| October 31, 2025 | 56.77% |
| September 30, 2025 | 56.77% |
| August 31, 2025 | 56.77% |
| July 31, 2025 | 56.77% |
| June 30, 2025 | 56.77% |
| May 31, 2025 | 56.77% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Sino Biopharmaceutical Ltd. | 77.71% |
| HUTCHMED (China) Ltd. | 82.18% |
| Lee's Pharmaceutical Holdings Ltd. | -- |
| AstraZeneca PLC | 27.87% |
| ANI Pharmaceuticals, Inc. | 72.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -17.90 |
| Beta (5Y) | 0.2730 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 26.26% |
| Historical Sharpe Ratio (5Y) | -0.5711 |
| Historical Sortino (5Y) | -0.5535 |